According to Zhitong Finance APP, Guangxi Wuzhou Zhongheng Group (600252.SH) announced that its holding subsidiary, Chongqing Lummy Pharmaceutical Co., Ltd. (abbreviated as "Lummy Pharmaceutical") participated in the tenth nationwide centralized pharmaceutical procurement bidding organized by the National Joint Procurement Office (abbreviated as "Joint Procurement Office"). According to the public announcement of the proposed selection results for nationwide pharmaceutical centralized procurement released by the Joint Procurement Office, Lummy Pharmaceutical's product Nimodipine injection is proposed to be selected for this centralized procurement.